Showing results (1261-1270 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|December 17, 2009
Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemiaAfrica González-Murillo, M Luz Lozano, Lara Alvarez, et al.Human Gene Therapy|February 2, 2010
Human NT2 neural precursor-derived tumor-infiltrating cells as delivery vehicles for treatment of glioblastomaYing Zhao, Shu WangHuman Gene Therapy|February 2, 2010
Molecular analysis of vector genome structures after liver transduction by conventional and self-complementary adeno-associated viral serotype vectors in murine and nonhuman primate modelsXun Sun, You Lu, Lawrence T Bish, et al.Human Gene Therapy|July 13, 2000
Gene therapy using hematopoietic stem cells: Sisyphus approaches the crestS Halene, D B KohnHuman Gene Therapy|July 13, 2000
Systemic production of human granulocyte colony-stimulating factor in nonhuman primates by transplantation of genetically modified myoblastsP A Moisset, L Bonham, D Skuk, et al.Human Gene Therapy|July 13, 2000
Potential of allospecific gene-engineered T cells in transplantation gene therapy: specific T cell activation determines transgene expression in vitro and in vivoM H Hammer, A Flügel, M Seifert, et al.Human Gene Therapy|July 26, 2000
Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vectorJ F Kukowska-Latallo, E Raczka, A Quintana, et al.Human Gene Therapy|July 26, 2000
A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoterS Koga, S Hirohata, Y Kondo, et al.Human Gene Therapy|July 26, 2000
Immunotherapy of a viral disease by in vivo production of therapeutic monoclonal antibodiesM Pelegrin, M Marin, A Oates, et al.Human Gene Therapy|July 26, 2000
Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiencyJ H Slingsby, D Baban, J Sutton, et al.Pageof 413